Formula Growth LTD Cerus Corp Transaction History

Formula Growth LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$5.25 - $8.56 $105,000 - $171,200	-20,000 Reduced 7.63%	242,290 $1.68 Million
Q1 2020 May 14, 2020	BUY	$2.87 - $5.49 $150,072 - $287,072	52,290 Added 24.9%	262,290 $1.22 Million
Q1 2019 May 14, 2019	SELL	$5.16 - $6.85 $77,400 - $102,750	-15,000 Reduced 6.67%	210,000 $1.31 Million
Q3 2018 Nov 14, 2018	SELL	$6.89 - $7.78 $68,900 - $77,800	-10,000 Reduced 4.26%	225,000 $1.62 Million
Q1 2018 May 15, 2018	BUY	$3.56 - $5.74 $836,600 - $1.35 Million	235,000 New	235,000 $1.29 Million
Q4 2017 Feb 14, 2018	SELL	$2.76 - $3.95 $872,794 - $1.25 Million	-316,230 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$2.22 - $2.73 $702,030 - $863,307	316,230	316,230 $863,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $317M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Formula Growth LTD, based on Form 13F filings with the SEC.

Stay updated on Formula Growth LTD with notifications on news.